Tolga Tanguler
Chief Commercial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Commercial Officer | $698,000 | $6,129,020 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Commercial Officer | $627,400 | $2,754,570 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Commercial Officer | $603,200 | $2,869,710 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Commercial Officer | $564,800 | $2,352,070 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | Executive Vice President, Chief Commercial Officer | $547,900 | $6,877,190 |
Earnings-call appearances
-
Alnylam Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-04-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-02-12
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-10-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-07-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-03-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-02
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-03
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-04
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-23
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-10-27
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-07-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-04-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-02-10
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-10-28
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-08-03
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-04-29
Alnylam Pharmaceuticals, Inc. (ALNY)
-
Alnylam Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2021-02-11
Alnylam Pharmaceuticals, Inc. (ALNY)